GO:0030170 pyridoxal phosphate binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0030170 pyridoxal phosphate binding describes the molecular function of binding to pyridoxal 5'-phosphate (PLP), the biologically active form of vitamin B6.
• PLP is an essential cofactor for numerous enzymes, forming a Schiff base with a conserved lysine residue in the active site.
• The binding of PLP to apoenzymes is highly specific and can be studied by spectroscopic methods such as circular dichroism.
• PLP also binds to non-enzymatic proteins like serum albumin, which may regulate its availability.
• The Escherichia coli protein YggS is a PLP-binding protein involved in PLP homeostasis, with lysine residues critical for binding.
• Studying PLP binding is relevant to understanding vitamin B6 metabolism, enzyme catalysis, and diseases linked to PLP-dependent enzymes.
Description
Pyridoxal phosphate binding (GO:0030170) is a molecular function that refers to the binding of pyridoxal 5'-phosphate (PLP), the active form of vitamin B6, to proteins. PLP is a versatile cofactor that participates in a wide range of enzymatic reactions, including transamination, decarboxylation, and racemization, primarily through the formation of a Schiff base with a lysine residue in the active site of apoenzymes. The binding of PLP to apoenzymes is a prerequisite for catalytic activity and is highly specific, as demonstrated by early studies using optical rotatory dispersion and circular dichroism. Beyond enzymatic roles, PLP also binds to proteins such as human serum albumin, which may serve as a reservoir or transporter of the cofactor. The study of PLP binding is therefore fundamental to understanding vitamin B6-dependent metabolism and the mechanisms of PLP-dependent enzymes. Recent research has expanded the scope of PLP-binding proteins, including the discovery that the ubiquitous PLP-binding protein is also an RNA-binding protein, and the characterization of YggS, a PLP homeostasis protein in Escherichia coli. These findings highlight the diverse roles of PLP binding in cellular physiology and the need for precise experimental approaches to dissect its functions.
pyridoxal phosphate binding At A Glance
| GO ID | GO:0030170 |
|---|---|
| GO term | pyridoxal phosphate binding |
| Ontology | molecular_function |
| Synonym | None |
| Major function | Binding to pyridoxal 5'-phosphate (PLP), the active form of vitamin B6, enabling its role as a cofactor in enzymatic reactions. |
| Definition source | QuickGO |
| Related proteins | PLP-dependent enzymes (e.g., transaminases, decarboxylases), serum albumin, YggS. |
| Biological importance | Essential for amino acid metabolism, neurotransmitter synthesis, and PLP homeostasis. |
What Is GO:0030170?
Pyridoxal phosphate binding (GO:0030170) is defined as the binding to pyridoxal 5' phosphate, 3-hydroxy-5-(hydroxymethyl)-2-methyl-4-pyridine carboxaldehyde 5' phosphate, the biologically active form of vitamin B6. This molecular function is essential for the activity of many enzymes that require PLP as a cofactor, and it involves specific interactions between the protein and the PLP molecule, often through a conserved lysine residue.
Why Is pyridoxal phosphate binding Important in Cell Biology?
Pyridoxal phosphate binding is crucial because PLP is an indispensable cofactor for numerous enzymes involved in amino acid metabolism, neurotransmitter biosynthesis, and other essential cellular processes. The binding of PLP to apoenzymes is a prerequisite for their catalytic activity, and defects in this process can lead to a variety of metabolic disorders. Moreover, PLP binding to proteins such as serum albumin influences the distribution and availability of vitamin B6 in the body. Understanding the molecular details of PLP binding is therefore fundamental to biochemistry, pharmacology, and medicine, and it provides insights into the mechanisms of PLP-dependent enzymes and their roles in health and disease.
• PLP is a cofactor for over 140 enzymatic activities, including transamination, decarboxylation, and racemization.
• PLP binding is essential for the function of enzymes involved in neurotransmitter synthesis, such as glutamate decarboxylase and aromatic L-amino acid decarboxylase.
• Defects in PLP-dependent enzymes are associated with neurological disorders, including epilepsy and pyridoxine-dependent seizures.
• PLP binding to serum albumin may regulate vitamin B6 homeostasis and influence drug interactions.
• The PLP homeostasis protein YggS is conserved across bacteria and eukaryotes, and its dysfunction affects cell growth.
• Studying PLP binding aids in the design of inhibitors and therapeutic agents targeting PLP-dependent enzymes.
• PLP-dependent catalytic antibodies have been generated, demonstrating the potential of PLP binding in biotechnology.
• The recent identification of PLP-binding proteins with RNA-binding activity suggests broader cellular roles for PLP.
Molecular Mechanism of pyridoxal phosphate binding
Formation of the Schiff Base
In simple terms: PLP attaches to a protein by forming a chemical bond with a specific amino acid, usually lysine.
The binding of pyridoxal 5'-phosphate (PLP) to apoenzymes typically involves the formation of a Schiff base between the aldehyde group of PLP and the epsilon-amino group of a conserved lysine residue in the active site. This covalent linkage is essential for catalysis and is often accompanied by a spectral shift that can be monitored by absorbance or circular dichroism. The specificity of this interaction is highlighted by studies showing that structural analogs of PLP can compete for binding and affect catalytic activity.
Conformational Changes and Spectral Properties
In simple terms: When PLP binds, the protein changes shape, which can be detected by light-based techniques.
Binding of PLP to apoenzymes induces conformational changes that can be observed using optical rotatory dispersion and circular dichroism. These spectroscopic methods reveal alterations in the protein's secondary structure and the environment of the bound cofactor. Such studies have been instrumental in understanding the mechanism of PLP-dependent enzymes and the role of specific residues in binding.
Non-Enzymatic PLP Binding Proteins
In simple terms: Some proteins bind PLP not to catalyze reactions but to transport or store it.
Human serum albumin binds PLP with high affinity, and this interaction may serve to regulate the concentration of free PLP in the bloodstream. The binding of PLP to albumin has been characterized using spectroscopic and equilibrium dialysis methods, revealing a specific binding site. Similarly, the Escherichia coli protein YggS binds PLP and is involved in maintaining PLP homeostasis; lysine residues in YggS are critical for PLP binding and protein stability.
PLP Binding in Catalytic Antibodies
In simple terms: Antibodies can be engineered to bind PLP and perform chemical reactions.
Pyridoxal-5'-phosphate-dependent catalytic antibodies have been generated by immunizing animals with a hapten that mimics the transition state of a PLP-dependent reaction. These antibodies catalyze reactions such as the elimination of beta-fluoroalanine, demonstrating that the immune system can be harnessed to create novel PLP-binding catalysts. This approach provides insights into the minimal requirements for PLP binding and catalysis.
RNA-Binding Activity of PLP-Binding Proteins
In simple terms: Some proteins that bind PLP can also bind RNA, suggesting dual functions.
Recent studies have shown that the ubiquitous PLP-binding protein also possesses RNA-binding activity, expanding its functional repertoire beyond cofactor binding. This dual binding capability may link PLP metabolism to RNA processing or regulation, although the physiological significance remains to be fully elucidated.
Key Genes Involved in GO:0030170 pyridoxal phosphate binding
The following genes and proteins are representative of those that bind pyridoxal phosphate and are commonly studied in the context of GO:0030170.
| Gene | Major Role | Research Relevance |
|---|---|---|
| GAD1 | Glutamate decarboxylase 1, synthesizes GABA | PLP-dependent enzyme; studied in epilepsy and neurotransmitter disorders |
| GAD2 | Glutamate decarboxylase 2, synthesizes GABA | PLP-dependent enzyme; target for neurological research |
| DDC | Dopa decarboxylase, synthesizes dopamine and serotonin | PLP-dependent enzyme; involved in Parkinson's disease |
| ALAS1 | Delta-aminolevulinate synthase 1, heme biosynthesis | PLP-dependent enzyme; studied in porphyria |
| ALAS2 | Delta-aminolevulinate synthase 2, erythroid heme biosynthesis | PLP-dependent enzyme; mutations cause X-linked sideroblastic anemia |
| OAT | Ornithine aminotransferase | PLP-dependent enzyme; deficiency causes gyrate atrophy |
| GPT | Glutamate pyruvate transaminase | PLP-dependent enzyme; liver function marker |
| GOT1 | Glutamate oxaloacetate transaminase 1 | PLP-dependent enzyme; involved in amino acid metabolism |
| GOT2 | Glutamate oxaloacetate transaminase 2 | PLP-dependent enzyme; mitochondrial aspartate aminotransferase |
| SHMT1 | Serine hydroxymethyltransferase 1 | PLP-dependent enzyme; one-carbon metabolism |
| SHMT2 | Serine hydroxymethyltransferase 2 | PLP-dependent enzyme; mitochondrial one-carbon metabolism |
| CBS | Cystathionine beta-synthase | PLP-dependent enzyme; deficiency causes homocystinuria |
| CTH | Cystathionine gamma-lyase | PLP-dependent enzyme; transsulfuration pathway |
| YggS | PLP homeostasis protein in E. coli | Bacterial model for PLP binding and homeostasis |
| ALB | Serum albumin | Binds PLP and regulates its distribution |
| PDXP | Pyridoxal phosphatase | Regulates PLP levels by dephosphorylation |
| PNPO | Pyridoxine 5'-phosphate oxidase | Produces PLP; mutations cause pyridoxine-dependent epilepsy |
| PLPBP | Pyridoxal phosphate binding protein | Ubiquitous PLP-binding protein with RNA-binding activity |
How Is pyridoxal phosphate binding Regulated?
The binding of pyridoxal phosphate to proteins is regulated at multiple levels. The availability of PLP is controlled by enzymes such as pyridoxine 5'-phosphate oxidase (PNPO) and pyridoxal phosphatase (PDXP), which synthesize and degrade PLP, respectively. In Escherichia coli, the YggS protein plays a role in PLP homeostasis, and its lysine residues are critical for PLP binding and protein stability. Additionally, the binding of PLP to serum albumin may modulate the free concentration of PLP in circulation. At the protein level, the formation of the Schiff base can be influenced by the local environment and the presence of specific residues that stabilize the interaction. Furthermore, the recent discovery that a PLP-binding protein also binds RNA suggests potential regulatory crosstalk between PLP metabolism and RNA processes.
pyridoxal phosphate binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PNPO | Pyridoxine-dependent epilepsy | Knockout or point-mutation cell models to study PLP synthesis and seizure susceptibility |
| CBS | Homocystinuria | Knock-in of patient mutations to assess PLP binding and enzyme activity |
| ALAS2 | X-linked sideroblastic anemia | Knockout and rescue with wild-type or mutant ALAS2 in erythroid cells |
| SHMT1/2 | Cancer metabolic reprogramming | Knockout and overexpression models to study one-carbon metabolism |
| YggS | Bacterial PLP homeostasis | Knockout in E. coli to study growth phenotypes and PLP binding |
Pyridoxine-Dependent Epilepsy
Mutations in genes involved in PLP metabolism, such as PNPO, can lead to pyridoxine-dependent epilepsy, a rare inherited disorder characterized by seizures that respond to vitamin B6 supplementation. The binding of PLP to its target enzymes is essential for normal brain function, and defects in this process can cause severe neurological symptoms.
Homocystinuria
Cystathionine beta-synthase (CBS) is a PLP-dependent enzyme, and its deficiency causes homocystinuria, a metabolic disorder with cardiovascular and neurological complications. The binding of PLP to CBS is required for its catalytic activity, and mutations that impair PLP binding can lead to enzyme dysfunction.
Sideroblastic Anemia
Delta-aminolevulinate synthase 2 (ALAS2) is a PLP-dependent enzyme involved in heme biosynthesis. Mutations in ALAS2 that affect PLP binding can cause X-linked sideroblastic anemia, highlighting the importance of PLP binding in red blood cell development.
Cancer and Metabolic Reprogramming
PLP-dependent enzymes such as serine hydroxymethyltransferase (SHMT) play key roles in one-carbon metabolism, which is often reprogrammed in cancer cells to support proliferation. Targeting PLP binding in these enzymes is an active area of cancer research.
From pyridoxal phosphate binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does a candidate gene bind PLP? | In vitro binding assays with purified protein and PLP |
| What is the role of a specific lysine in PLP binding? | Point mutation (e.g., K-to-A) knock-in cell lines |
| How does PLP binding affect enzyme activity? | Knockout cell line complemented with wild-type or binding-deficient mutant |
| Does PLP binding regulate protein stability? | Tagged knock-in for degradation studies (e.g., dTAG) |
| Can PLP binding be targeted therapeutically? | Overexpression of PLP-binding protein in disease models |
| What are the global effects of PLP binding disruption? | CRISPR knockout followed by RNA-seq and proteomics |
How to Study the pyridoxal phosphate binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Circular dichroism | Conformational changes upon PLP binding | Studying apoenzyme-to-holoenzyme transition |
| Equilibrium dialysis | Binding affinity (Kd) and stoichiometry | Characterizing PLP binding to serum albumin |
| Absorbance spectroscopy | Schiff base formation | Monitoring PLP binding to enzymes |
| X-ray crystallography | Three-dimensional structure of PLP-protein complex | Determining atomic details of binding site |
| CRISPR knockout | Gene function in PLP binding | Identifying essential genes for PLP homeostasis |
| RNA-seq | Transcriptional changes | Global effects of PLP-binding protein knockout |
| Proteomics | Protein abundance and interactions | Identifying PLP-binding proteins and complexes |
| Site-directed mutagenesis | Role of specific residues in PLP binding | Testing lysine mutants in YggS |
Spectroscopic Methods for PLP Binding
Circular dichroism and optical rotatory dispersion are classical techniques used to study PLP binding to apoenzymes, providing information on conformational changes and binding stoichiometry. Absorbance spectroscopy can monitor the formation of the Schiff base, which has a characteristic absorption peak around 430 nm.
Equilibrium Dialysis and Binding Assays
Equilibrium dialysis and ultrafiltration are used to measure the affinity of PLP for proteins such as serum albumin. These methods allow determination of dissociation constants and binding site numbers.
Genetic and Genomic Approaches
CRISPR-Cas9 knockout screens can identify genes required for PLP binding and homeostasis. RNA-seq and proteomics can reveal global changes in gene expression and protein abundance upon disruption of PLP-binding proteins.
Structural Biology
X-ray crystallography and NMR spectroscopy provide atomic-level details of PLP binding sites and the conformational changes induced by cofactor binding. These methods are essential for understanding the molecular basis of PLP-dependent catalysis.
How CRISPR Can Be Used to Study GO:0030170 pyridoxal phosphate binding
Knockout
CRISPR-Cas9 knockout of genes encoding PLP-binding proteins can reveal their essentiality and downstream effects. For example, knockout of YggS in E. coli affects PLP homeostasis and cell growth. In human cells, knockout of PLP-dependent enzymes can be used to study metabolic pathways and disease mechanisms.
Point Mutation
Point mutations can be introduced to specifically disrupt PLP binding without affecting other functions. For instance, mutating the conserved lysine residue in YggS abolishes PLP binding and reduces protein stability. Such models are valuable for dissecting the contribution of PLP binding to enzyme activity and cellular physiology.
Knock-in
Knock-in of disease-associated mutations in PLP-binding proteins allows study of their functional consequences in a physiological context. For example, knock-in of PNPO mutations linked to pyridoxine-dependent epilepsy can model the disease in cell lines. Tagged knock-in (e.g., GFP or dTAG) enables visualization and controlled degradation of PLP-binding proteins.
Overexpression
Overexpression of PLP-binding proteins can be used to study their effects on cellular metabolism and to produce recombinant protein for biochemical assays. Overexpression of serum albumin can modulate PLP availability in culture media.
How EDITGENE Supports pyridoxal phosphate binding Research
Researchers studying pyridoxal phosphate binding-related genes often need to determine whether a candidate gene is causally involved in PLP-dependent processes, and to dissect the molecular details of PLP binding. EDITGENE provides a comprehensive suite of CRISPR-based services to enable such investigations.
Contact EDITGENE today to design your custom CRISPR model for pyridoxal phosphate binding research.
Frequently Asked Questions About pyridoxal phosphate binding
What is pyridoxal phosphate binding?
Pyridoxal phosphate binding (GO:0030170) is the molecular function of binding to pyridoxal 5'-phosphate (PLP), the active form of vitamin B6, which serves as a cofactor for many enzymes.
What genes are involved in pyridoxal phosphate binding?
Genes encoding PLP-dependent enzymes such as GAD1, GAD2, DDC, ALAS1, ALAS2, OAT, GPT, GOT1, GOT2, SHMT1, SHMT2, CBS, and CTH, as well as PLP-binding proteins like YggS and PLPBP.
How does PLP bind to proteins?
PLP typically binds via a Schiff base linkage to a conserved lysine residue in the active site of apoenzymes, a process that can be studied by spectroscopic methods.
What is the role of pyridoxal phosphate in metabolism?
PLP is a cofactor for numerous metabolic reactions, including transamination, decarboxylation, and racemization, essential for amino acid and neurotransmitter metabolism.
Which diseases are associated with defects in pyridoxal phosphate binding?
Defects can cause pyridoxine-dependent epilepsy, homocystinuria, sideroblastic anemia, and other metabolic disorders.
How can I study pyridoxal phosphate binding in the lab?
Techniques include circular dichroism, equilibrium dialysis, X-ray crystallography, and CRISPR-based genetic screens.
What is the function of YggS in PLP binding?
YggS is a PLP homeostasis protein in E. coli; its lysine residues are critical for PLP binding and protein stability.
Can CRISPR be used to study PLP binding?
Yes, CRISPR knockout, point mutation, and knock-in models can be used to dissect the roles of PLP-binding proteins in cells.
What is the difference between PLP and pyridoxal?
PLP is pyridoxal 5'-phosphate, the phosphorylated and biologically active form of vitamin B6, while pyridoxal is its precursor.
How does serum albumin interact with PLP?
Serum albumin binds PLP with high affinity, potentially regulating its distribution and availability in the bloodstream.
Conclusion
Pyridoxal phosphate binding (GO:0030170) is a fundamental molecular function that underpins the activity of numerous enzymes and regulatory proteins. Understanding the mechanisms, genes, and diseases associated with PLP binding is essential for basic and translational research. With the help of advanced CRISPR technologies, researchers can now precisely manipulate PLP-binding proteins to uncover their roles in health and disease.
References
- 1. Graziani C et al.. 2024. The ubiquitous pyridoxal 5'-phosphate-binding protein is also an RNA-binding protein.. Protein Sci 33(12):e5242 PMID: 39604152
- 2. John RA. 1995. Pyridoxal phosphate-dependent enzymes.. Biochim Biophys Acta 1248(2):81-96 PMID: 7748903
- 3. Gamov GA et al.. 2020. Binding of pyridoxal, pyridoxal 5'-phosphate and derived hydrazones to bovine serum albumin in aqueous solution.. Spectrochim Acta A Mol Biomol Spectrosc 233:118165 PMID: 32120288
- 4. Hayaishi O et al.. 1970. Binding of pyridoxal phosphate to apoenzymes as studied by optical rotatory dispersion and circular dichroism.. Vitam Horm 28:245-64 PMID: 4946802
- 5. Snell EE. 1970. Analogs of pyridoxal or pyridoxal phosphate: relation of structure to binding with apoenzymes and to catalytic activity.. Vitam Horm 28:265-90 PMID: 4946803
- 6. Fonda ML et al.. 1991. The binding of pyridoxal 5'-phosphate to human serum albumin.. Arch Biochem Biophys 288(1):79-86 PMID: 1898027
- 7. Gramatikova SI et al.. 2000. Pyridoxal-5'-phosphate-dependent catalytic antibodies.. Appl Biochem Biotechnol 83(1-3):183-90; discussion 190-3, 297-313 PMID: 10826959
- 8. Tramonti A et al.. 2022. Characterization of the Escherichia coli pyridoxal 5'-phosphate homeostasis protein (YggS): Role of lysine residues in PLP binding and protein stability.. Protein Sci 31(11):e4471 PMID: 36218140
